Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion

NCT02302365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2018-07-03

Study results available
· View outcomes & findings →

Summary

This study is a multicenter, retrospective data collection of routine clinical use with the Spectra Optia® apheresis system for white blood cell depletion.

Conditions

  • Leukocytosis

Interventions

DEVICE

Spectra Optia® Apheresis System

White Blood Cell Depletion

Sponsors & Collaborators

  • Terumo BCT

    lead INDUSTRY

Principal Investigators

  • Isobelle Galeon, MD, MPH, MSCS · Medical Monitor, Clinical Safety

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Belgium
  • Germany
  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02302365 on ClinicalTrials.gov